Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 42, pseudogene (RNU6-42P) is a sequence in the human genome similar to the canonical U6 small nuclear RNA gene but rendered non-protein-coding and non-functional by mutations or rearrangements. U6 snRNA is a highly conserved and essential component of the spliceosome responsible for pre-mRNA splicing, with many functional copies and pseudogenes scattered through the vertebrate genome[7]. The RNU6-42P locus is one such pseudogene, and while its functional counterparts (canonical U6 snRNA genes) participate in crucial splicing activities, no data support a role for RNU6-42P transcripts or encoded RNA in splicing or any other biological process[1]. Pseudogenes are generally catalogued for informational completeness and do not encode proteins or active RNAs in most cases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 42, pseudogene (RNU6-42P).